New diabetes clinical trial: Effects of SGLT2 Inhibitors on Islet Cell Function and Insulin Sensitivity in Patients of Type 2 Diabetes Mellitus

Published on: July 10, 2019 at 07:00PM
Condition:   Type 2 Diabetes Mellitus
Intervention:   Drug: Dapagliflozin, Empagliflozin and Canagliflozin
Sponsor:   Peking Union Medical College Hospital
Not yet recruiting